Top Markets
Coin of the day
AmCad BioMed Corporation AmCad BioMed Corporation

AmCad BioMed Corporation

4188
Rangering i aksjer #29617
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Aksjekurs
$0.32117018
Markedsverdi
$20.34M
Endring (1 dag)
-0.98%
Endring (1 år)
-34.41%
Land
TW
Handel AmCad BioMed Corporation (4188)

Kategori

P/S-forhold for AmCad BioMed Corporation (4188)
P/S-forhold per 2026 TTM: 0
Ifølge AmCad BioMed Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for AmCad BioMed Corporation fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
5.25 -
DE
- -
CA
3.75 -
US
2.80 -
US
8.70 -
US